AT
Andrew Tsai Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
51%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Real Estate
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Real Estate
Real Estate Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $32 |
73%
upside
| 1 | +39% |
0
%
| 21 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $25 |
86%
upside
| 1 | +0.22% |
0
%
| 12 Nov ‘25 23 days ago |
|
|
|
Hold
Downgraded
| $20 |
6%
downside
| 1 | – |
–
| 22 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $300 |
21%
upside
| 1 | +332% |
0
%
| 16 Oct ‘25 1 month ago |
|
|
|
Hold
Downgraded
| $56 |
3%
upside
| 1 | – |
–
| 9 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $190 |
5%
upside
| 1 | +32% |
0
%
| 25 Sep ‘25 2 months ago |
|